MIT chemical engineers have developed a new sensor that lets them see inside cancer cells and determine whether the cells are responding to a particular type of chemotherapy drug.
The sensors, which detect hydrogen peroxide inside human cells, could help researchers identify new cancer drugs that boost levels of hydrogen peroxide, which induces programmed cell death. The sensors could also be adapted to screen individual patients’ tumors to predict whether such drugs would be effective against them.
“The same therapy isn’t going to work against all tumors,” says Hadley Sikes, an associate professor of chemical engineering at MIT. “Currently there’s a real dearth of quantitative, chemically specific tools to be able to measure the changes that occur in tumor cells versus normal cells in response to drug treatment.”
Sikes is the senior author of the study, which appears in the Aug. 7 issue of Nature Communications. The paper’s first author is graduate student Troy Langford; other authors are former graduate students Beijing Huang and Joseph Lim and graduate student Sun Jin Moon.
Tracking hydrogen peroxide
Cancer cells often have mutations that cause their metabolism to go awry and produce abnormally high fluxes of hydrogen peroxide. When too much of the molecule is produced, it can damage cells, so cancer cells become highly dependent on antioxidant systems that remove hydrogen peroxide from cells.
Drugs that target this vulnerability, which are known as “redox drugs,” can work by either disabling the antioxidant systems or further boosting production of hydrogen peroxide. Many such drugs have entered clinical trials, with mixed results.
“One of the problems is that the clinical trials usually find that they work for some patients and they don’t work for other patients,” Sikes says. “We really need tools to be able to do more well-designed trials where we figure out which patients are going to respond to this approach and which aren’t, so more of these drugs can be approved.”
To help move toward that goal, Sikes set out to design a sensor that could sensitively detect hydrogen peroxide inside human cells, allowing scientists to measure a cell’s response to such drugs.
Existing hydrogen peroxide sensors are based on proteins called transcription factors, taken from microbes and engineered to fluoresce when they react with hydrogen peroxide. Sikes and her colleagues tried to use these in human cells but found that they were not sensitive in the range of hydrogen peroxide they were trying to detect, which led them to seek human proteins that could perform the task.
Through studies of the network of human proteins that become oxidized with increasing hydrogen peroxide, the researchers identified an enzyme called peroxiredoxin that dominates most human cells’ reactions with the molecule. One of this enzyme’s many functions is sensing changes in hydrogen peroxide levels.
Langford then modified the protein by adding two fluorescent molecules to it — a green fluorescent protein at one end and a red fluorescent protein at the other end. When the sensor reacts with hydrogen peroxide, its shape changes, bringing the two fluorescent proteins closer together. The researchers can detect whether this shift has occurred by shining green light onto the cells: If no hydrogen peroxide has been detected, the glow remains green; if hydrogen peroxide is present, the sensor glows red instead.
The researchers tested their new sensor in two types of human cancer cells: one set that they knew was susceptible to a redox drug called piperlongumine, and another that they knew was not susceptible. The sensor revealed that hydrogen peroxide levels were unchanged in the resistant cells but went up in the susceptible cells, as the researchers expected.
Sikes envisions two major uses for this sensor. One is to screen libraries of existing drugs, or compounds that could potentially be used as drugs, to determine if they have the desired effect of increasing hydrogen peroxide concentration in cancer cells. Another potential use is to screen patients before they receive such drugs, to see if the drugs will be successful against each patient’s tumor. Sikes is now pursuing both of these approaches.
“You have to know which cancer drugs work in this way, and then which tumors are going to respond,” she says. “Those are two separate but related problems that both need to be solved for this approach to have practical impact in the clinic.”
The Latest on: Cancer therapy
via Google News
The Latest on: Cancer therapy
- Elizabeth Hurley takes part in research into breast cancer treatment on October 8, 2018 at 7:15 am
The actress, 53, hailed the work as "ground-breaking" during a visit to the laboratory at Brighton and Sussex Medical School, where the team is exploring whether stress reduction techniques can increa... […]
- Immunotherapy effective for individuals with inherited form of skin cancer on October 8, 2018 at 12:37 am
Individuals with an inherited form of skin cancer often have a poor prognosis ... Institutet and elsewhere have examined how effective immunological checkpoint therapy is for individuals with inherite... […]
- ‘I need to rest’, says Lee after cancer treatment on October 7, 2018 at 11:09 pm
KUALA LUMPUR: Malaysian badminton ace Lee Chong Wei says he needs to be left alone to rest for at least a few days after returning home following nose cancer treatment in Taiwan. The world number five ... […]
- Veracyte presents new data on Afirma GSC and Afirma Xpression Atlas therapies for thyroid cancer on October 7, 2018 at 10:41 pm
"Additionally, the wide range of gene alterations detected by the Xpression Atlas may provide further insights into pathway activation and potential cancer treatment targets for patients with thyroid ... […]
- Analysis reveals genomic effects of a new cancer treatment now in clinical trials on October 7, 2018 at 3:07 pm
A twist on the molecular mechanism of how a new cancer drug works could aid in better identifying the best treatments for patients for an array of cancers. The team identified over 500 sites in DNA th... […]
- Festival of the Wheel Car Show Supports Cancer Treatment on October 7, 2018 at 2:45 pm
The first ever Virginia Festival of the Wheel car show took place at the Sprint Pavilion in Downtown Charlottesville on Sunday. The event was planned to celebrate cars, but also cancer survivors. One ... […]
- NW Harris County hospitals offer breast cancer screening, treatment options on October 7, 2018 at 10:20 am
Dr. Ali Mazloom, from left, and Dr. Uzma Iqbal, both physicians at Cypress Fairbanks Medical Center's Cancer Center, chat with radiation therapist Nallely Sandoval about the linear accelerator at the ... […]
- Prevention and early treatment are key to overcoming breast cancer on October 7, 2018 at 12:00 am
Breast cancer is caused by an uncontrolled growth of breast cells. Which type of breast cancer you have depends on the type of cell from the cancer it is derived from. The breast itself is a collectio... […]
- Artist's exhibit shows her journey through cancer treatment on October 6, 2018 at 11:16 pm
LONGVIEW, Wash. (AP) - When her cancer treatment isolated her from the world, Longview resident Anne-Marie Carr used her art to reach out. Carr created a piece of art every day for 100 days during her ... […]
via Bing News